BG107908A - Инхибитори на фарнезилтрансфераза - Google Patents

Инхибитори на фарнезилтрансфераза Download PDF

Info

Publication number
BG107908A
BG107908A BG107908A BG10790803A BG107908A BG 107908 A BG107908 A BG 107908A BG 107908 A BG107908 A BG 107908A BG 10790803 A BG10790803 A BG 10790803A BG 107908 A BG107908 A BG 107908A
Authority
BG
Bulgaria
Prior art keywords
methyl
imidazol
cyanophenyl
biphenyl
hydroxy
Prior art date
Application number
BG107908A
Other languages
Bulgarian (bg)
English (en)
Inventor
Akyo K. Claiborne
Stephen L. Gwaltney Ii
Lisa A. Hasvold
Qun Li
Tomgmei Li
Nan-Horng Lin
Robert A. Mantei
Todd W. Rockway
Hing L. Sham
Gerard M. Sullivan
Yunsong Tong
Gary T. Wang
Le Wang
Xilu Wang
Weibo Wang
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of BG107908A publication Critical patent/BG107908A/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
BG107908A 2000-11-30 2003-06-13 Инхибитори на фарнезилтрансфераза BG107908A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72723000A 2000-11-30 2000-11-30
US09/912,677 US20020115640A1 (en) 2000-11-30 2001-07-25 Farnesyltransferase inhibitors
PCT/US2001/043168 WO2002074747A1 (en) 2000-11-30 2001-11-30 Farnesyltransferase inhibitors

Publications (1)

Publication Number Publication Date
BG107908A true BG107908A (bg) 2004-01-30

Family

ID=24921844

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107908A BG107908A (bg) 2000-11-30 2003-06-13 Инхибитори на фарнезилтрансфераза

Country Status (31)

Country Link
US (1) US20020115640A1 (zh)
EP (1) EP1339695B1 (zh)
JP (1) JP2004519503A (zh)
KR (1) KR20030060968A (zh)
CN (1) CN1487924A (zh)
AR (1) AR035375A1 (zh)
AT (1) ATE323681T1 (zh)
BG (1) BG107908A (zh)
BR (1) BR0112028A (zh)
CA (1) CA2430619A1 (zh)
CY (1) CY1106104T1 (zh)
CZ (1) CZ20031804A3 (zh)
DE (1) DE60118955T2 (zh)
DK (1) DK1339695T3 (zh)
EC (1) ECSP034634A (zh)
ES (1) ES2261340T3 (zh)
HK (1) HK1059260A1 (zh)
HU (1) HUP0600331A2 (zh)
IL (2) IL156212A0 (zh)
MX (1) MXPA03004879A (zh)
MY (1) MY136181A (zh)
NO (1) NO20032471L (zh)
NZ (1) NZ526313A (zh)
PE (1) PE20020687A1 (zh)
PL (1) PL363637A1 (zh)
PT (1) PT1339695E (zh)
SA (1) SA01220565B1 (zh)
SI (1) SI1339695T1 (zh)
SK (1) SK286686B6 (zh)
UY (1) UY27046A1 (zh)
WO (1) WO2002074747A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008539276A (ja) * 2005-04-27 2008-11-13 ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インコーポレイティド ヒト疾患に関連する変異体タンパク質の分解能を改善するための材料及び方法
JP4592548B2 (ja) * 2005-08-24 2010-12-01 株式会社エヌ・ティ・ティ・ドコモ 送信電力制御方法及び移動通信システム
US7722316B2 (en) * 2005-09-13 2010-05-25 Rolls-Royce Power Engineering Plc Acoustic viscous damper for centrifugal gas compressor
US7790770B2 (en) 2005-11-23 2010-09-07 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
TW200806284A (en) * 2006-03-31 2008-02-01 Alcon Mfg Ltd Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
US8084477B2 (en) * 2007-10-31 2011-12-27 Bristol-Myers Squibb Company Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
AU2009263037B2 (en) * 2008-06-26 2011-10-06 Amgen Inc. Alkynyl alcohols as kinase inhibitors
WO2012069193A1 (de) * 2010-11-26 2012-05-31 Reza Ghotbi Implant zur behandlung oder prävention eines aneurysmas
CN105693617B (zh) * 2014-11-24 2018-06-08 中国科学院大连化学物理研究所 一种tmsn3参与的还原环化反应制备4-咪唑甲醛衍生物的方法
US10177604B2 (en) 2015-10-07 2019-01-08 Tc1 Llc Resonant power transfer systems having efficiency optimization based on receiver impedance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997036901A1 (en) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6297239B1 (en) * 1997-10-08 2001-10-02 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
ES2237125T3 (es) * 1998-08-27 2005-07-16 Pfizer Products Inc. Derivados de quinolin-2-ona utiles como agentes anticancerigenos.

Also Published As

Publication number Publication date
IL156212A (en) 2008-11-26
MY136181A (en) 2008-08-29
PL363637A1 (en) 2004-11-29
NO20032471D0 (no) 2003-05-30
JP2004519503A (ja) 2004-07-02
CN1487924A (zh) 2004-04-07
NO20032471L (no) 2003-07-25
PT1339695E (pt) 2006-08-31
DE60118955T2 (de) 2007-01-04
US20020115640A1 (en) 2002-08-22
UY27046A1 (es) 2002-07-31
EP1339695A1 (en) 2003-09-03
IL156212A0 (en) 2003-12-23
PE20020687A1 (es) 2002-08-03
HUP0600331A2 (en) 2006-10-28
ECSP034634A (es) 2003-07-25
CA2430619A1 (en) 2002-09-26
WO2002074747A1 (en) 2002-09-26
SK286686B6 (sk) 2009-03-05
DE60118955D1 (de) 2006-05-24
NZ526313A (en) 2004-11-26
SK8232003A3 (en) 2004-01-08
MXPA03004879A (es) 2004-05-04
KR20030060968A (ko) 2003-07-16
SI1339695T1 (sl) 2006-10-31
CY1106104T1 (el) 2011-06-08
ATE323681T1 (de) 2006-05-15
AR035375A1 (es) 2004-05-12
HK1059260A1 (en) 2004-06-25
DK1339695T3 (da) 2006-07-31
EP1339695B1 (en) 2006-04-19
SA01220565B1 (ar) 2007-01-27
CZ20031804A3 (cs) 2003-11-12
ES2261340T3 (es) 2006-11-16
BR0112028A (pt) 2004-02-17

Similar Documents

Publication Publication Date Title
JP3207901B2 (ja) レトロウイルス阻害性化合物
US8598168B2 (en) Inhibitors of histone deacetylase
CN101184734B (zh) 治疗细胞增殖紊乱的化合物和方法
JP5001505B2 (ja) 新規チオウレア誘導体およびこれを含有する薬学的組成物
KR100893804B1 (ko) 히스톤 데아세틸라아제의 억제제
JP3827324B2 (ja) 金属タンパク質分解酵素阻害剤
US7323570B2 (en) Farnesyltransferase inhibitors
KR20100107509A (ko) 히스톤 데아세틸라아제의 억제제
JP2006503019A (ja) メタロプロテイナーゼmmp12のインヒビターとしての2,5−ジオキソイミダゾリジン−4−イルアセトアミドおよび類似体
CA2548849A1 (en) Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease
SK48499A3 (en) Heteroaryl succinamides and their use as metalloproteinase inhibitors
SK25199A3 (en) Heterocyclic metalloprotease inhibitors
BG103433A (bg) Бензамидоалдехиди и тяхното използване като инхибитори на цистеинпротеаза
EA039144B1 (ru) Новые гетероариламидные производные как селективные ингибиторы гистондеацетилаз 1 и/или 2 (hdac1-2)
BG107908A (bg) Инхибитори на фарнезилтрансфераза
WO2000007985A1 (fr) Nouveaux derives d'uree renfermant des heterocycles aromatiques azotes
US6812237B2 (en) N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
JP2002212179A (ja) 新規アニリド誘導体又はその塩及びこれを含有する医薬
EP1283825B1 (en) N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
JPH0558997A (ja) チオカルバモイルアセトニトリル誘導体
AU2001297704B2 (en) Farnesyltransferase inhibitors
JP2024500427A (ja) Erap阻害剤
SK283634B6 (sk) Butadiénový, aminobutadiénový a pyrolidínový derivát a spôsoby ich prípravy
AU2001297704A1 (en) Farnesyltransferase inhibitors
JPH05194429A (ja) アゾール化合物、その製造法および用途